College of
Human
Medicine

Nicholas V. Perricone, M.D., Division of Dermatology Research

Research Summary

  • Pimiento JM, Larkin EM, Smalley KS, Wiersma GL, Monks NR, Fedorenko IV, Peterson CA, Nickoloff BJ. Melanoma genotypes and phenotypes get personal. Lab Invest 93:858-867, 2013

  • Andersen NJ, Nickoloff BJ, Dykema K, Boguslawski EA, Krivochenitser R, Froman R, Dawes M, Baker M D L, Thomas D, Kamstock D, Kitchell B, Furge KA, Duesbery NS. Pharmacological inhibition of MEK signaling prevents growth of canine hemagiosarcoma. Mol Cancer Therapeutcis 12: 1701-1714, 2013

  • Nickoloff BJ, Vande Woude G: Hepatocyte Growth Factor in the neighborhood reverses resistance to BRAF inhibitor in melanoma. J Pigment Cell and Melanoma Research,25: 758-761, 2012.

  • Monsma DJ, Monks NR, Cherba DM, Dylewski D, Eugster E, Jahn H, Srikanth S, Scott SB, Richardson PJ, Verets RE, Ishkin A, Nikolsky Y, Resau JH, Sigler R, Nickoloff BJ, Webb CP: Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue. J Translat Med, 10: 125-134, 2012.

  • Qin JZ, Xin H, Nickoloff BJ: Specifically targeting ERK1 or ERK2 kills melanoma cells. J Translat Med, 10: 15-26, 2012.
Research